575 related articles for article (PubMed ID: 33229544)
1. ATP13A2-mediated endo-lysosomal polyamine export counters mitochondrial oxidative stress.
Vrijsen S; Besora-Casals L; van Veen S; Zielich J; Van den Haute C; Hamouda NN; Fischer C; Ghesquière B; Tournev I; Agostinis P; Baekelandt V; Eggermont J; Lambie E; Martin S; Vangheluwe P
Proc Natl Acad Sci U S A; 2020 Dec; 117(49):31198-31207. PubMed ID: 33229544
[TBL] [Abstract][Full Text] [Related]
2. ATP13A2 deficiency disrupts lysosomal polyamine export.
van Veen S; Martin S; Van den Haute C; Benoy V; Lyons J; Vanhoutte R; Kahler JP; Decuypere JP; Gelders G; Lambie E; Zielich J; Swinnen JV; Annaert W; Agostinis P; Ghesquière B; Verhelst S; Baekelandt V; Eggermont J; Vangheluwe P
Nature; 2020 Feb; 578(7795):419-424. PubMed ID: 31996848
[TBL] [Abstract][Full Text] [Related]
3. ATP13A2 Regulates Cellular α-Synuclein Multimerization, Membrane Association, and Externalization.
Si J; Van den Haute C; Lobbestael E; Martin S; van Veen S; Vangheluwe P; Baekelandt V
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33799982
[TBL] [Abstract][Full Text] [Related]
4. Dysregulated iron metabolism in C. elegans catp-6/ATP13A2 mutant impairs mitochondrial function.
Anand N; Holcom A; Broussalian M; Schmidt M; Chinta SJ; Lithgow GJ; Andersen JK; Chamoli M
Neurobiol Dis; 2020 Jun; 139():104786. PubMed ID: 32032734
[TBL] [Abstract][Full Text] [Related]
5. Structural basis of polyamine transport by human ATP13A2 (PARK9).
Sim SI; von Bülow S; Hummer G; Park E
Mol Cell; 2021 Nov; 81(22):4635-4649.e8. PubMed ID: 34715013
[TBL] [Abstract][Full Text] [Related]
6. Structural mechanisms for gating and ion selectivity of the human polyamine transporter ATP13A2.
Tillinghast J; Drury S; Bowser D; Benn A; Lee KPK
Mol Cell; 2021 Nov; 81(22):4650-4662.e4. PubMed ID: 34715014
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial dysfunction, oxidative stress, and neurodegeneration elicited by a bacterial metabolite in a C. elegans Parkinson's model.
Ray A; Martinez BA; Berkowitz LA; Caldwell GA; Caldwell KA
Cell Death Dis; 2014 Jan; 5(1):e984. PubMed ID: 24407237
[TBL] [Abstract][Full Text] [Related]
8. Novel Green Fluorescent Polyamines to Analyze ATP13A2 and ATP13A3 Activity in the Mammalian Polyamine Transport System.
Houdou M; Jacobs N; Coene J; Azfar M; Vanhoutte R; Van den Haute C; Eggermont J; Daniëls V; Verhelst SHL; Vangheluwe P
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830711
[TBL] [Abstract][Full Text] [Related]
9. ATP13A2/PARK9 regulates endo-/lysosomal cargo sorting and proteostasis through a novel PI(3, 5)P2-mediated scaffolding function.
Demirsoy S; Martin S; Motamedi S; van Veen S; Holemans T; Van den Haute C; Jordanova A; Baekelandt V; Vangheluwe P; Agostinis P
Hum Mol Genet; 2017 May; 26(9):1656-1669. PubMed ID: 28334751
[TBL] [Abstract][Full Text] [Related]
10. Hereditary Parkinsonism-Associated Genetic Variations in PARK9 Locus Lead to Functional Impairment of ATPase Type 13A2.
Park JS; Sue CM
Curr Protein Pept Sci; 2017; 18(7):725-732. PubMed ID: 26965689
[TBL] [Abstract][Full Text] [Related]
11. A lipid switch unlocks Parkinson's disease-associated ATP13A2.
Holemans T; Sørensen DM; van Veen S; Martin S; Hermans D; Kemmer GC; Van den Haute C; Baekelandt V; Günther Pomorski T; Agostinis P; Wuytack F; Palmgren M; Eggermont J; Vangheluwe P
Proc Natl Acad Sci U S A; 2015 Jul; 112(29):9040-5. PubMed ID: 26134396
[TBL] [Abstract][Full Text] [Related]
12. Polyamines in Parkinson's Disease: Balancing Between Neurotoxicity and Neuroprotection.
Vrijsen S; Houdou M; Cascalho A; Eggermont J; Vangheluwe P
Annu Rev Biochem; 2023 Jun; 92():435-464. PubMed ID: 37018845
[TBL] [Abstract][Full Text] [Related]
13. Overlapping expression patterns and functions of three paralogous P5B ATPases in Caenorhabditis elegans.
Zielich J; Tzima E; Schröder EA; Jemel F; Conradt B; Lambie EJ
PLoS One; 2018; 13(3):e0194451. PubMed ID: 29547664
[TBL] [Abstract][Full Text] [Related]
14. The Parkinson-associated human P5B-ATPase ATP13A2 modifies lipid homeostasis.
Marcos AL; Corradi GR; Mazzitelli LR; Casali CI; Fernández Tome MDC; Adamo HP; de Tezanos Pinto F
Biochim Biophys Acta Biomembr; 2019 Oct; 1861(10):182993. PubMed ID: 31132336
[TBL] [Abstract][Full Text] [Related]
15. Parkinson's disease-associated human ATP13A2 (PARK9) deficiency causes zinc dyshomeostasis and mitochondrial dysfunction.
Park JS; Koentjoro B; Veivers D; Mackay-Sim A; Sue CM
Hum Mol Genet; 2014 Jun; 23(11):2802-15. PubMed ID: 24399444
[TBL] [Abstract][Full Text] [Related]
16. Regulation of ATP13A2 via PHD2-HIF1α Signaling Is Critical for Cellular Iron Homeostasis: Implications for Parkinson's Disease.
Rajagopalan S; Rane A; Chinta SJ; Andersen JK
J Neurosci; 2016 Jan; 36(4):1086-95. PubMed ID: 26818499
[TBL] [Abstract][Full Text] [Related]
17. Parkinson's disease-associated human P5B-ATPase ATP13A2 increases spermidine uptake.
De La Hera DP; Corradi GR; Adamo HP; De Tezanos Pinto F
Biochem J; 2013 Feb; 450(1):47-53. PubMed ID: 23205587
[TBL] [Abstract][Full Text] [Related]
18. Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78).
Estrada-Cuzcano A; Martin S; Chamova T; Synofzik M; Timmann D; Holemans T; Andreeva A; Reichbauer J; De Rycke R; Chang DI; van Veen S; Samuel J; Schöls L; Pöppel T; Mollerup Sørensen D; Asselbergh B; Klein C; Zuchner S; Jordanova A; Vangheluwe P; Tournev I; Schüle R
Brain; 2017 Feb; 140(2):287-305. PubMed ID: 28137957
[TBL] [Abstract][Full Text] [Related]
19. CATP-6, a C. elegans ortholog of ATP13A2 PARK9, positively regulates GEM-1, an SLC16A transporter.
Lambie EJ; Tieu PJ; Lebedeva N; Church DL; Conradt B
PLoS One; 2013; 8(10):e77202. PubMed ID: 24130856
[TBL] [Abstract][Full Text] [Related]
20. Lysosomal Storage of Subunit c of Mitochondrial ATP Synthase in Brain-Specific Atp13a2-Deficient Mice.
Sato S; Koike M; Funayama M; Ezaki J; Fukuda T; Ueno T; Uchiyama Y; Hattori N
Am J Pathol; 2016 Dec; 186(12):3074-3082. PubMed ID: 27770614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]